Loading...
Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase
BACKGROUND & OBJECTIVES: Imatinib is the standard first-line treatment for chronic myeloid leukaemia (CML) patients. About 20 to 30 per cent patients develop resistance to imatinib and fail imatinib treatment. One of the mechanisms proposed is varying expression levels of the drug transporters....
Na minha lista:
| Udgivet i: | Indian J Med Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613438/ https://ncbi.nlm.nih.gov/pubmed/26354214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5916.164250 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|